These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 11496102)

  • 1. (1)H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging.
    Catani M; Cherubini A; Howard R; Tarducci R; Pelliccioli GP; Piccirilli M; Gobbi G; Senin U; Mecocci P
    Neuroreport; 2001 Aug; 12(11):2315-7. PubMed ID: 11496102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T.
    Kantarci K; Reynolds G; Petersen RC; Boeve BF; Knopman DS; Edland SD; Smith GE; Ivnik RJ; Tangalos EG; Jack CR
    AJNR Am J Neuroradiol; 2003 May; 24(5):843-9. PubMed ID: 12748083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy.
    Metastasio A; Rinaldi P; Tarducci R; Mariani E; Feliziani FT; Cherubini A; Pelliccioli GP; Gobbi G; Senin U; Mecocci P
    Neurobiol Aging; 2006 Jul; 27(7):926-32. PubMed ID: 15936850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's disease.
    Catani M; Mecocci P; Tarducci R; Howard R; Pelliccioli GP; Mariani E; Metastasio A; Benedetti C; Senin U; Cherubini A
    J Am Geriatr Soc; 2002 Oct; 50(10):1707-10. PubMed ID: 12366626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
    Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal proton MR spectroscopy in early Alzheimer's disease and mild cognitive impairment.
    Foy CM; Daly EM; Glover A; O'Gorman R; Simmons A; Murphy DG; Lovestone S
    Brain Topogr; 2011 Oct; 24(3-4):316-22. PubMed ID: 21298332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proton spectroscopy in Alzheimer's disease and cognitive impairment not dementia: a community study].
    Azevedo D; Bottino CM; Tatsch M; Hototian SR; Bazzarella MC; Castro CC
    Arq Neuropsiquiatr; 2005 Dec; 63(4):1021-7. PubMed ID: 16400423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
    Pilatus U; Lais C; Rochmont Adu M; Kratzsch T; Frölich L; Maurer K; Zanella FE; Lanfermann H; Pantel J
    Psychiatry Res; 2009 Jul; 173(1):1-7. PubMed ID: 19427767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study.
    Kantarci K; Jack CR; Xu YC; Campeau NG; O'Brien PC; Smith GE; Ivnik RJ; Boeve BF; Kokmen E; Tangalos EG; Petersen RC
    Neurology; 2000 Jul; 55(2):210-7. PubMed ID: 10908893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z; Zhao C; Yu L; Zhou W; Li K
    Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy.
    Weiss U; Bacher R; Vonbank H; Kemmler G; Lingg A; Marksteiner J
    J Clin Psychiatry; 2003 Mar; 64(3):235-42. PubMed ID: 12716263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
    Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance spectroscopy in mild cognitive impairment: systematic review and meta-analysis.
    Tumati S; Martens S; Aleman A
    Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 2):2571-86. PubMed ID: 23969177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early proton magnetic resonance spectroscopy in normal-appearing brain correlates with outcome in patients following traumatic brain injury.
    Garnett MR; Blamire AM; Corkill RG; Cadoux-Hudson TA; Rajagopalan B; Styles P
    Brain; 2000 Oct; 123 ( Pt 10)():2046-54. PubMed ID: 11004122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton magnetic resonance spectroscopy of late-life major depressive disorder.
    Chen CS; Chiang IC; Li CW; Lin WC; Lu CY; Hsieh TJ; Liu GC; Lin HF; Kuo YT
    Psychiatry Res; 2009 Jun; 172(3):210-4. PubMed ID: 19303260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated brain scyllo-inositol concentrations in patients with Alzheimer's disease.
    Griffith HR; den Hollander JA; Stewart CC; Evanochko WT; Buchthal SD; Harrell LE; Zamrini EY; Brockington JC; Marson DC
    NMR Biomed; 2007 Dec; 20(8):709-16. PubMed ID: 17295394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cognitive impairment: classification by proton magnetic resonance spectroscopy and the contributions of conventional magnetic resonance imaging].
    Martínez-Bisbal MC; Arana E; Martí-Bonmatí L; Martínez-Granados B; Celda B
    Radiologia; 2006; 48(5):301-7. PubMed ID: 17168239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI.
    Jessen F; Gür O; Block W; Ende G; Frölich L; Hammen T; Wiltfang J; Kucinski T; Jahn H; Heun R; Maier W; Kölsch H; Kornhuber J; Träber F
    Neurology; 2009 May; 72(20):1735-40. PubMed ID: 19451528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cerebral metabolism in patients with cognitive disorders: a combined MRS and PET study].
    Khomenko YG; Kataeva GV; Bogdan AA; Chernysheva EM; Susin DS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(1):51-58. PubMed ID: 30778031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.